switching from semaglutide to liraglutide Tirzepatide Liraglutide vs semaglutide: a head-to-head
Description
JAMA 2016;316:500508
The SURMOUNT-1 study was a placebo-controlled 72-week trial in obese subjects that randomized 2,539 participants without diabetes into four equally large study arms with placebo or one of the three tirzepatide doses (5, 10, or 15 mg once weekly)
References: Romantsova, T
That led to approval for using the medications in people with obesity
native added
Canada's approval of the generic GLP-1s comes after India this year approved dozens of low-cost versions, causing a price scramble that has prompted Novo Nordisk to cut the prices of Ozempic and Wegovy by nearly 50% in that country
